Top 4 Stocks In The Drugs-Generic Industry With The Highest Cash

by Monica Gerson, Benzinga Staff Writer

October 8, 2013 4:45 AM | 1 min read | Make a Comment

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash. Salix Pharmaceuticals

SLXP

had $817.98 million in total cash and $875.74 million in total debt for the latest quarter. Mylan

MYL

had $360.07 million in total cash for the latest quarter. However, Mylan had $6.22 billion in total debt for the same period. Hi-Tech Pharmacal Co

HITK

had $108.28 million in total cash and $1.15 million in total debt for the latest quarter. Akorn

AKRX

had $58.41 million in total cash and $106.66 million in total debt for the latest quarter.

Posted In: Trading Ideas Cash Drugs-Generic Industry

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.